Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... Company

A world free of pain. This is our shared vision. To bring it to life, we execute our strategy and work on our company’s culture – everyday, everywhere, every one of us.

... We are Grünenthal

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

The Supervisory Board advises and controls the Corporate Executive Board and is elected by the shareholders’ summit.

... Supervisory Board

In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Grünenthal’s product portfolio, brands, ingredients and indication range.

... Products

... Our positions

Explore our media section and access a range of materials relating to our company, people, medicines and medical devices.

... Media

Grünenthal is a global leader in pain management and related diseases. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain. Explore our recent stories to see what drives us.

... Our Stories

In this section you will find both current and archived press releases published from 2013 onwards by Grünenthal GmbH, Germany.

... Press releases

... Statements

Journalists are invited to use our corporate publications for their reporting. The list contains business related publication like the company presentation or the code of conduct. .

... Corporate publications

Journalists are invited to use images from our library to illustrate their reporting. The library contains company and R&D related pictures.

... Image resources

The library contains a set of company footage. Journalists are invited to use the video material to illustrate their reporting.

... Video resources

Our Corporate Responsibility Programme

Corporate responsibility is at the core of our business strategy and culture. It runs through everything we do. We want to create a net positive impact for patients, employees, partners and wider society, and work towards reducing our impact on the environment. To make this happen, we have established impact initiatives with ambitious goals. Our performance is regularly rated by an independent agency according to environmental, social and governance (ESG) criteria.

The different modules of our Corporate Responsibility Programme

Diagram: The four modules of our Corporate Responsibility Programme

To make sure that we create a positive impact in everything we do, our Corporate Responsibility Programme is built on four modules: Fields of Action, Ethical Framework, ESG Risk Management and Corporate Governance. We ensure maximum positive impact through our four fields of action. Our stringent ethical framework guides us how we work. An independent agency regularly monitors and assesses our environmental, social and governance risk. Our corporate governance system ensures that we constantly live our values.

Our Fields of Action – for maximum positive impact

Our four fields of action make sure that we create maximum positive impact. For each field, we have identified material – or relevant and essential – topics with specific ambitions and KPIs. You can find details about these measures on the respective subpages.

Compliance, Ethics and Transparency

Maintaining excellence in the areas of compliance, ethics and transparency is at the core of our daily work. We aim to operate our business with the highest ethical standards, and we strive for continuous improvement.

Our Impact Initiatives

The ambitious goals, structured in our five impact initiatives, are built in a way to optimise the positive impact for the people we work with, the patients we serve and to reduce our impact on the environment. These include:

Patient

Female Doctor in an online appointment with a patient

Impact initiative “Education of Patients & Healthcare Professionals”

– educating healthcare professionals on the responsible use of pain medicines and thereby supporting patients on their journey to achieving optimal pain management.

Impact initiative “Data-driven Human Disease Understanding”

– building our understanding of human disease to enhance our ability to create truly novel medicines for patients in need.

Impact initiative “Global Grünenthal Platform for Awareness & Access”

– establishing one joint platform to ensure access to medicine and raise awareness about pain and palliative care; thereby improving accessibility for patients to adequate pain treatment, particularly among underserved populations.

People

Planet

Hand holding a crystal ball which reflects a Grünenthal building from our Campus in Aachen, Germany

Impact initiative “Circle of Trust”

– establishing a “Diversity & Engagement Council” to foster a culture of trust among employees, partners and the community.

Impact initiative “Driving Environmental Sustainability”

– using resources sustainably, avoiding waste in our operations, working with our suppliers to reduce environmental impacts and working towards powering our sites with low carbon or renewable energy sources.

Our ESG Risk Rating

Our performance in environmental, social and governance (ESG) criteria is reflected in an external rating by Sustainalytics. We were attributed a medium ESG risk. This places Grünenthal in the top three percent of the global pharmaceuticals subindustry that inherently features higher ESG risk.